CGEN Intrinsic Valuation and Fundamental Analysis - Compugen Ltd - Alpha Spread

Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.83 USD 0.55% Market Closed
Market Cap: 163.8m USD
Have any thoughts about
Compugen Ltd?
Write Note

Intrinsic Value

CGEN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CGEN stock under the Base Case scenario is 2.14 USD. Compared to the current market price of 1.83 USD, Compugen Ltd is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGEN Intrinsic Value
2.14 USD
Undervaluation 15%
Intrinsic Value
Price
Base Case Scenario
How do you feel about CGEN?
Bearish
Neutral
Bullish

Valuation Backtest
Compugen Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling CGEN based on its intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Wall St Estimates
Price Target
Loading
Revenue Forecast
Operating Income Forecast
Earnings Forecast
No Indicators Selected
Select Indicators
Investor Returns
Shareholder Yield
Dividend Safety
Dividend Yield
Dividend Payout Ratio
Buyback Yield
Debt Paydown Yield
No Indicators Selected
Select Indicators
Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Compugen Ltd

Provide an overview of the primary business activities
of Compugen Ltd.

What unique competitive advantages
does Compugen Ltd hold over its rivals?

What risks and challenges
does Compugen Ltd face in the near future?

Summarize the latest earnings call
of Compugen Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Compugen Ltd.

Provide P/S
for Compugen Ltd.

Provide P/E
for Compugen Ltd.

Provide P/OCF
for Compugen Ltd.

Provide P/FCFE
for Compugen Ltd.

Provide P/B
for Compugen Ltd.

Provide EV/S
for Compugen Ltd.

Provide EV/GP
for Compugen Ltd.

Provide EV/EBITDA
for Compugen Ltd.

Provide EV/EBIT
for Compugen Ltd.

Provide EV/OCF
for Compugen Ltd.

Provide EV/FCFF
for Compugen Ltd.

Provide EV/IC
for Compugen Ltd.

Show me price targets
for Compugen Ltd made by professional analysts.

What are the Revenue projections
for Compugen Ltd?

How accurate were the past Revenue estimates
for Compugen Ltd?

What are the Net Income projections
for Compugen Ltd?

How accurate were the past Net Income estimates
for Compugen Ltd?

What are the EPS projections
for Compugen Ltd?

How accurate were the past EPS estimates
for Compugen Ltd?

What are the EBIT projections
for Compugen Ltd?

How accurate were the past EBIT estimates
for Compugen Ltd?

Compare the revenue forecasts
for Compugen Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Compugen Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Compugen Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Compugen Ltd compared to its peers.

Compare the P/E ratios
of Compugen Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Compugen Ltd with its peers.

Analyze the financial leverage
of Compugen Ltd compared to its main competitors.

Show all profitability ratios
for Compugen Ltd.

Provide ROE
for Compugen Ltd.

Provide ROA
for Compugen Ltd.

Provide ROIC
for Compugen Ltd.

Provide ROCE
for Compugen Ltd.

Provide Gross Margin
for Compugen Ltd.

Provide Operating Margin
for Compugen Ltd.

Provide Net Margin
for Compugen Ltd.

Provide FCF Margin
for Compugen Ltd.

Show all solvency ratios
for Compugen Ltd.

Provide D/E Ratio
for Compugen Ltd.

Provide D/A Ratio
for Compugen Ltd.

Provide Interest Coverage Ratio
for Compugen Ltd.

Provide Altman Z-Score Ratio
for Compugen Ltd.

Provide Quick Ratio
for Compugen Ltd.

Provide Current Ratio
for Compugen Ltd.

Provide Cash Ratio
for Compugen Ltd.

What is the historical Revenue growth
over the last 5 years for Compugen Ltd?

What is the historical Net Income growth
over the last 5 years for Compugen Ltd?

What is the current Free Cash Flow
of Compugen Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Compugen Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Compugen Ltd

Current Assets 102.1m
Cash & Short-Term Investments 92m
Receivables 9.8m
Other Current Assets 333k
Non-Current Assets 8m
Long-Term Investments 3m
PP&E 4.1m
Other Non-Current Assets 922k
Current Liabilities 24.8m
Accounts Payable 4.9m
Accrued Liabilities 8.7m
Other Current Liabilities 11.3m
Non-Current Liabilities 27.1m
Other Non-Current Liabilities 27.1m
Efficiency

Earnings Waterfall
Compugen Ltd

Revenue
42.7m USD
Cost of Revenue
-5.7m USD
Gross Profit
37.1m USD
Operating Expenses
-41.6m USD
Operating Income
-4.5m USD
Other Expenses
-5m USD
Net Income
-9.5m USD

Free Cash Flow Analysis
Compugen Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CGEN Profitability Score
Profitability Due Diligence

Compugen Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
32/100
Profitability
Score

Compugen Ltd's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

CGEN Solvency Score
Solvency Due Diligence

Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
56/100
Solvency
Score

Compugen Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGEN Price Targets Summary
Compugen Ltd

Wall Street analysts forecast CGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGEN is 5.1 USD with a low forecast of 4.04 USD and a high forecast of 7.35 USD.

Lowest
Price Target
4.04 USD
121% Upside
Average
Price Target
5.1 USD
179% Upside
Highest
Price Target
7.35 USD
302% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CGEN?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for CGEN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Want to learn more about CGEN dividends, buybacks, and debt paydown yield?

Click here to dive deeper.

CGEN Price
Compugen Ltd

1M 1M
+5%
6M 6M
-38%
1Y 1Y
+74%
3Y 3Y
-73%
5Y 5Y
-53%
10Y 10Y
-80%
Annual Price Range
1.83
52w Low
0.53
52w High
2.95
Price Metrics
Average Annual Return 4.68%
Standard Deviation of Annual Returns 93.7%
Max Drawdown -97%
Shares Statistics
Market Capitalization 163.8m USD
Shares Outstanding 89 530 200
Percentage of Shares Shorted 2.02%

Competitive Landscape

Profile

Compugen Ltd Logo
Compugen Ltd

Country

Israel

Industry

Life Sciences Tools & Services

Market Cap

163.8m USD

Dividend Yield

0%

Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. The firm focuses on infrastructure to discover drug targets and develop therapeutics. The firm is engaged in the research, development and commercialization of therapeutic and product candidates. The firm's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Contact

Holon
Azrieli Center, 26 Harokmim St. Bldg D
+97237658585.0
www.cgen.com

IPO

2000-08-01

Employees

73

Officers

See Also

Discover More
What is the Intrinsic Value of one CGEN stock?

The intrinsic value of one CGEN stock under the Base Case scenario is 2.14 USD.

Is CGEN stock undervalued or overvalued?

Compared to the current market price of 1.83 USD, Compugen Ltd is Undervalued by 15%.

Back to Top